Related Experiment Video
Updated: Jan 5, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.0K
Identification of prognostic biomarkers for malignant melanoma using microarray datasets.
Guanyu Lin1, Guoqian Yin1, Yuyong Yan1
1Department of Plastic and Aesthetic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Oncology Letters
|October 18, 2019
Summary
This study identified key genes involved in melanoma development by analyzing gene expression data. These findings offer potential new targets for melanoma diagnosis and treatment.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Malignant melanoma is a prevalent cancer with unclear molecular mechanisms.
- Understanding melanoma's molecular pathology is crucial for effective treatment.
Purpose of the Study:
- To identify candidate genes and molecular pathways involved in melanoma initiation and progression.
- To uncover potential diagnostic and therapeutic targets for melanoma.
Main Methods:
- Analysis of microarray datasets (GSE3189, GSE4570, GSE4587) from the Gene Expression Omnibus database.
- Identification of differentially expressed genes (DEGs), functional enrichment analysis, and protein-protein interaction network construction using STRING and Cytoscape.
- Survival analysis and Oncomine database analysis.
Main Results:
- Identified 182 DEGs (52 downregulated, 130 upregulated) in melanoma.
- Enriched pathways include GTPase activity, apoptosis, cell adhesion, calcium signaling, and PI3K-Akt signaling.
- Discovered 10 hub genes and highlighted calmodulin family, BAX, and VEGFA genes' potential association with melanoma progression.
Conclusions:
- The identified DEGs and hub genes provide insights into melanoma's molecular pathways.
- This research may facilitate the development of novel diagnostic and therapeutic strategies for melanoma.
